"Internet + Medical" Shanghai test water single disease health management

At the end of 2015, Shanghai Fudan University Affiliated Tumor Hospital launched the full-brain management model of breast health, and proposed the concept of full-process management of single disease health for the first time in the world. So how does the full-service management model of breast health work in 3 months? What about the effect?

Internet + medical

The reporter found that the whole process of breast health management is centered on healthy people and patients, and uses Internet tools to match health education, screening, diagnosis, multidisciplinary treatment, follow-up, etc. in all aspects related to breast health. Medical resources, providing appropriate medical services, in order to promote medical treatment measures such as graded diagnosis and treatment, two-way referral.

Speaking of the original intention of the establishment of the whole process management model, Shao Zhimin, director of the Breast Surgery Department of Fudan University Cancer Hospital explained: "The essence of the whole breast health management model is based on the overall structural optimization of the department and the re-allocation of medical resources, to achieve the graded diagnosis and treatment inside the department, not just It is only a change in the process. Therefore, it can truly touch the core of medical services and reflect the value of doctor services. It is a single-process health management platform for healthy people and patients led by medical institutions."

Supported by WeChat platform

The Maternal Health Whole Management Platform is based on the WeChat platform and serves as a core platform for serving healthy people and hospital-treated breast cancer patients. It is an information platform for mission, screening, diagnosis, surgery, decision-making, dispensing, and follow-up. The business function sections of dozens of subsystems in the three sections of “medical assistance”, “personal center” and “science education”.

At the end of 2015, the e-health public management platform of the Breast Cancer Affiliated Tumor Hospital of Fudan University was opened. The WeChat public account was opened. More than 5,800 fans were gathered in 3 months. The number of fans treated in the Cancer Hospital was close to 2,500.

Patients in hospitalization only need to pay attention to the “e-follow-up” public number, upload their own inspection report photos in the column of the interpretation report, and give professional guidance to the team of doctors in the background. In case of difficult cases or patients with metastasis and recurrence, the background physician The situation will be fed back to the attending physician, and a multidisciplinary discussion will be held once a week, and an appointment will be made for the patient's follow-up clinic. This will solve the diagnosis and treatment process that the patient has completed in the past two weeks, and the compression process will be solved within 1.5 hours. After more than three months of operation, the background physicians conducted a remote interpretation report for more than 350 patients.

Breast disease management is gradually moving towards the "slow disease management" model. The Breast Health Whole Management Platform has customized a “Health Passport” for each inpatient, which can be considered a health management file with a unique ID. Each patient reviewed the knowledge of the mission and documented the treatment process to improve the health awareness and follow-up of “chronic management” in breast cancer patients.

Management platform gives pre-distribution

Shanghai Fudan University Affiliated Tumor Hospital has carried out many reforms in breast surgery, including referral bonus, follow-up bonus, process bonus, image addition and so on.

Director Shao Zhimin introduced that the so-called guide card addition is also called diagnosing. Patients can make appointments through WeChat platform. We guarantee that patients can see the disease the next day, but see what doctors need to be screened, and the patients in the background will be diverted from patients who need surgery. To the expert number, the experts directly register the patient through the background, do not need to pass the paper plus, the old patients who are followed up are diverted to the doctor.

During the follow-up of cancer patients, some problems often occur. For example, after the first year of operation, the follow-up is very high, but the second and third years are slowly decreasing. How to improve the follow-up rate is a problem faced by every doctor.

To this end, the attending doctor will teach the patient to join the breast health management platform. After the patient has any problems, he can directly communicate with the doctor on the platform, and can send inspection reports to each other, and the doctor will answer them in time. Shao Zhimin said that after such a mutual trust relationship was established, patient satisfaction was high, which brought convenience for future follow-up. This is the follow-up bonus.

For a long time, breast cancer patients first look at breast surgery, re-registered with a chemotherapy doctor after surgery, and re-registered with a radiologist after chemotherapy. Nowadays, the breast health management platform has established a multi-disciplinary oncology, which links multiple doctors' groups, so that patients do not take the road in the internal process, which not only improves the medical service and satisfaction, but also greatly improves the efficiency.

The reporter found that patients manage the new model throughout the process, breaking the inherent treatment process. During the follow-up, some patients were assigned to dispense medicines, which enabled the patients to “distribute on demand” to free up scarce resources for more patients with newly diagnosed and intractable diseases. The “Mobile Physician” on the palm and the convenient appointment consultation channel have improved the patient experience. The data show that from July to September 2015, the amount of breast surgery in the Cancer Hospital increased by 20% and the median waiting time decreased by 15%. In general outpatients, the total amount of medicines increased by 25% year-on-year, and the median waiting time decreased by 50%.

When each patient is discharged from the hospital, the surgeon management platform will give him a passport. The precautions, follow-up and treatment on the passport are clear, especially the patient's tumor classification, and she is also written to let the patient know that she is What kind of classification is it, what treatment is needed afterwards. Shao Zhimin told reporters that although the platform has greatly helped patients' follow-up and management and follow-up treatment, this is only preliminary and is still being improved constantly, especially how to cooperate among multiple disciplines. This is our future. Content that is constantly being explored.

Fertility Tests

In vitro diagnosis of fertility mainly includes the following three categories:
1. HCG Pregnancy Test is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

2.The One Step LH Urine Ovulation Test is fast and easy to use. It is a qualitative test that can predict when there is a LH (luteinizing hormone) surge, and in turn, when you are likely to ovulate.

3.One Step FSH Menopause Test is a rapid, one-step, visual test for the qualitative detection of follicle stimulating hormone (FSH) in human urine. It is to be used as a confirmation of body hormone changes related to the symptoms associated with the changes of menopause and as an adjunctive screen of fertility for home use by women who are attempting to conceive but have been unsuccessful.

Precaution
1. For in vitro diagnostic use only
2. This reagent is designed for the qualitative screening test. A confirmed pregnancy diagnosis should
be made only by a physician after all clinical and laboratory findings have been evaluated.
3. Do not use test kit beyond expiry date.
4. The test device should not be reused.
5. Do not use other kinds of quality control sample to test the reagent. Components of different
batches cannot be exchanged for use to avoid erroneous results

Fertility Tests,Early Pregnancy Hcg Test,Lh Ovulation Test,Fsh Menopause Test

Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com